Worldwide, TB is one of the top 10 causes of death, and the leading cause from a single infectious agent (above HIV / AIDS). According to a WHO report, India saw 2.7
million TB cases (incidence + relapse) in 2017. India accounted for 27% of global TB deaths. Globally, 3.5% of new TB cases and 18% of previously treated cases had multi-drug resistant/rifampicin resistant TB (MDR/RR-TB). India is one of the top 3 countries with the largest number of MDR/RR-TB cases that constitute 47% of global MDR/RR-TB cases.
MedGenome's whole genome sequencing of MTB covers all drug resistance markers and can also be used for strain typing, epidemiology studies and disease surveillance.
|TAT||15 working days|
|Sample Specimen||Sterile container- To be transported within 24 hours in cold condition|
|Additional Requirements||Duly filled TRF with available TB test reports|